Business Context and Reporting Period
This Form 8-K Current Report was filed by Marchex, Inc. on December 30, 2021. The filing details the entry into material definitive agreements regarding executive compensation for the 2022 fiscal year, including cash bonus plans and equity awards.
Key Financial Metrics and Compensation Details
The filing does not report operational financial metrics such as revenue, profit, cash flow, or debt. Instead, it discloses specific compensation figures:
- Aggregate Target Bonus Pool: $568,438 for initial executive officer participants (Michael Arends and Russell Horowitz).
- Maximum Bonus Pool: 195% of the target amount.
- Individual Target Bonuses: $250,000 for John Roswech (Chief Revenue Officer) and $200,000 for Ryan Polley (Chief Operating Officer).
- Equity Grants:
- Russell C. Horowitz: 47,500 stock options and 47,500 restricted shares.
- Michael Arends: 98,000 stock options and 98,000 restricted shares.
Material Changes and Performance Targets
Compensation is tied to specific performance targets relative to 2021 levels:
- Bonus Metrics: Weighted 33 1/3% each on new revenue, total revenue, and adjusted OIBA.
- Equity Acceleration Triggers:
- 50% Vesting: Revenue exceeding 120% of 2021 levels, adjusted OIBA exceeding specified multiples of 2021, or share price exceeding 150% of the initial 2021 average for 20 consecutive trading days.
- Remaining Vesting: Revenue exceeding 127% of 2021 levels, higher adjusted OIBA multiples, or share price exceeding 160% of the initial 2021 average for 20 consecutive trading days.
Outlook, Risks, and Contingencies
Management has established a compensation structure contingent on achieving significant growth in revenue and adjusted OIBA compared to 2021. The equity awards include a "Double-Trigger Change in Control Acceleration" provision. The filing does not provide specific forward-looking guidance on company performance beyond these compensation thresholds.
Investor Verification Checklist
- Verify the closing price of Class B Common Stock on December 30, 2021, to calculate the fair value of the granted options and restricted stock.
- Review the 2021 fiscal year revenue and adjusted OIBA figures to assess the feasibility of the 120% and 127% growth targets required for equity acceleration.
- Confirm the specific "adjusted OIBA" multiples defined in the internal plan documents, as the filing references them without stating the exact numerical multiples.
- Monitor the share price for 20 consecutive trading days to determine if the 150% or 160% price targets are met.